Toll-like receptor 4: A potential therapeutic target for multiple human diseases

被引:23
|
作者
Wei, Jinrui [1 ,2 ,3 ]
Zhang, Yan [1 ,2 ,3 ]
Li, Haopeng [1 ,2 ,3 ]
Wang, Fuquan [1 ,2 ,3 ]
Yao, Shanglong [1 ,2 ,3 ,4 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Anesthesiol, Wuhan 430022, Peoples R China
[2] Huazhong Univ Sci & Technol, Union Hosp, Inst Anesthesia & Crit Care Med, Tongji Med Coll, Wuhan 430022, Peoples R China
[3] Huazhong Univ Sci & Technol, Key Lab Anesthesiol & Resuscitat, Minist Educ, Hongshan, Peoples R China
[4] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Anesthesiol, 1277 Jiefang Ave, Wuhan 430022, Peoples R China
关键词
Immune response; Toll -like receptor 4; Cardiovascular; Neoplastic; Inflammatory; NF-KAPPA-B; ESOPHAGEAL CANCER-CELLS; TRAUMATIC BRAIN-INJURY; NLRP3; INFLAMMASOME; REGULATORY FACTOR-3; ADHESION MOLECULES; SIGNALING PATHWAYS; ACTIVATION; TLR4; LIPOPOLYSACCHARIDE;
D O I
10.1016/j.biopha.2023.115338
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The immune response plays a pivotal role in the pathogenesis of diseases. Toll-like receptor 4 (TLR4), as an intrinsic immune receptor, exhibits widespread in vivo expression and its dysregulation significantly contributes to the onset of various diseases, encompassing cardiovascular disorders, neoplastic conditions, and inflammatory ailments. This comprehensive review centers on elucidating the architectural and distributive characteristics of TLR4, its conventional signaling pathways, and its mode of action in diverse disease contexts. Ultimately, this review aims to propose novel avenues and therapeutic targets for clinical intervention.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Targeting the Toll of Drug Abuse: The Translational Potential of Toll-Like Receptor 4
    Bachtell, Ryan
    Hutchinson, Mark R.
    Wang, Xiaohui
    Rice, Kenner C.
    Maier, Steven F.
    Watkins, Linda R.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2015, 14 (06) : 692 - 699
  • [2] Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer's Disease
    Wu, Linyu
    Xian, Xiaohui
    Xu, Guangyu
    Tan, Zixuan
    Dong, Fang
    Zhang, Min
    Zhang, Feng
    MEDIATORS OF INFLAMMATION, 2022, 2022
  • [3] Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure
    Engelmann, Cornelius
    Sheikh, Mohammed
    Sharma, Shreya
    Kondo, Takayuki
    Loeffler-Wirth, Henry
    Zheng, Yu Bao
    Novelli, Simone
    Hall, Andrew
    Kerbert, Annarein J. C.
    Macnaughtan, Jane
    Mookerjee, Rajeshwar
    Habtesion, Abeba
    Davies, Nathan
    Ali, Tauhid
    Gupta, Saurabh
    Andreola, Fausto
    Jalan, Rajiv
    JOURNAL OF HEPATOLOGY, 2020, 73 (01) : 102 - 112
  • [4] Toll-like receptors as a potential therapeutic target for atherosclerosis and cardiovascular disease
    Lacheta, Dominika
    Olejarz, Wioletta
    Wrzosek, Malgorzata
    Nowicka, Grazyna
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2018, 72 : 728 - 739
  • [5] Toll-Like Receptor as a Potential Biomarker in Renal Diseases
    Mertowski, Sebastian
    Lipa, Paulina
    Morawska, Izabela
    Niedzwiedzka-Rystwej, Paulina
    Bebnowska, Dominika
    Hrynkiewicz, Rafal
    Grywalska, Ewelina
    Rolinski, Jacek
    Zaluska, Wojciech
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (18) : 1 - 27
  • [6] Tracing the evolution of novel features of human Toll-like receptor 4
    Anderson, Jeremy A.
    Loes, Andrea N.
    Waddell, Grace L.
    Harms, Michael J.
    PROTEIN SCIENCE, 2019, 28 (07) : 1350 - 1358
  • [7] Toll-like Receptor 3 Is a Therapeutic Target for Pulmonary Hypertension
    Farkas, Daniela
    Thompson, A. A. Roger
    Bhagwani, Aneel R.
    Hultman, Schuyler
    Ji, Hyun
    Kotha, Naveen
    Farr, Grant
    Arnold, Nadine D.
    Braithwaite, Adam
    Casbolt, Helen
    Cole, Jennifer E.
    Sabroe, Ian
    Monaco, Claudia
    Cool, Carlyne D.
    Goncharova, Elena A.
    Lawrie, Allan
    Farkas, Laszlo
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199 (02) : 199 - 210
  • [8] Innate immune receptor Toll-like receptor 4 signalling in neuropsychiatric diseases
    Garcia Bueno, B.
    Caso, J. R.
    Madrigal, J. L. M.
    Leza, J. C.
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2016, 64 : 134 - 147
  • [9] Multiple roles of toll-like receptor 4 in colorectal cancer
    Yesudhas, Dhanusha
    Gosu, Vijayakumar
    Anwar, Muhammad Ayaz
    Choi, Sangdun
    FRONTIERS IN IMMUNOLOGY, 2014, 5
  • [10] Links between Toll-like receptor 4 and breast cancer
    Ahmed, Abubakr
    Redmond, H. Paul
    Wang, Jiang Huai
    ONCOIMMUNOLOGY, 2013, 2 (02):